Menu

D. Bron MD, PhD

Jules Bordet Institute, 7318

Articles

P1.16 Monoclonal B-cell lymphocytosis (MBL): results olmpact of extracellular vesicles from mesenchymal stromal cells-based microenvironment on Chronic Lymphocytic Leukemia B-cells

BJH - volume 6, issue Abstract Book BHS, january 2015

E. Crompot , M. Van Damme , H. Duvillier , K. Pieters , P. Mineur MD, N. Meuleman MD, PhD, D. Bron MD, PhD, L.L. Lagneaux , B. Stamatopoulous

Read more

P1.17 DNA hydroxymethylation in chronic lymphocytic leukemia: TET and IDH mRNA expression, prognostic significance and influence of microenvironment

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Van Damme , E. Crompot , N. Meuleman MD, PhD, P. Mineur MD, D. Bron MD, PhD, L. Lagneaux , B. Stamatopoulos

Read more

P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)

BJH - volume 6, issue Abstract Book BHS, january 2015

G. Claes MD, J. Nguyen , N. Charette , G. Machiels , M. Vercruyssen MD, S. Wittnebel MD, PhD, N. Meuleman MD, PhD, D. Bron MD, PhD

Read more

P4.07 Diagnosis of congenital von Willebrand disease during a pre-operative screening in a multiple myeloma patient

BJH - volume 6, issue Abstract Book BHS, january 2015

M. EI Ouaaliti , L Rong , P. Nguyen , D. Gobin , D. Bron MD, PhD, B. Cantinieaux

Read more

P1.03 Thymoquinone induces DNA damage, apoptosis and inhibits proliferation in germinal center subtype of diffuse large B-cell lymphoma

BJH - volume 6, issue Abstract Book BHS, january 2015

M. Berehab , R. Rouas , D. Douaa , D. Bron MD, PhD, P. Lewalle MD, PhD, P. Martiat MD, PhD, M. Merimi

Read more

BHS guidelines for the treatment of marginal zone lymphomas

BJH - volume 5, issue 1, march 2014

D. Bron MD, PhD, E. Van den Neste MD, PhD, A. Kentos MD, PhD, F. Offner MD, PhD, W. Schroyens MD, PhD, C. Bonnet MD, A. Van Hoof MD, PhD, G. Verhoef MD, PhD, A. Janssens MD, PhD

Summary

Marginal zone lymphomas are a heterogeneous subtype of indolent B-non-Hodgkin Lymphoma that includes three distinct diseases: Extranodal mucosa associated lymphoid tissue lymphoma, nodal marginal zone lymphoma and splenic marginal zone lymphoma lymphocytes +/− villous lymphocytes. The different diagnosis, work up and treatment options are discussed in these guidelines.

(BELG J HEMATOL 2014;5(1):12–21)

Read more

P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients

BJH - volume 5, issue Abstract Book BHS, january 2014

B. Stamatopoulos , N. Meuleman MD, PhD, E. Crompot , M. Van Damme , B. Dessars MD, PhD, H. El Housni , P. Mineur MD, D. Bron MD, PhD, L. Lagneaux

Read more
Top